RWM
BSX icon

RBA Wealth Management’s Boston Scientific BSX Stock Holding History

RBA Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Buy
71,213
+7,476
+12% +$406K 1.12% 43
2026
Q1 		$4M Buy
63,737
+1,368
+2% +$109K 1.44% 36
2025
Q4 		$5.95M Buy
62,369
+198
+0.3% +$19.4K 2.01% 17
2025
Q3 		$6.07M Sell
62,171
-1,137
-2% -$118K 2.09% 17
2025
Q2 		$6.8M Sell
63,308
-3,512
-5% -$355K 2.53% 9
2025
Q1 		$6.74M Sell
66,820
-583
-0.9% -$58.7K 2.67% 7
2024
Q4 		$6.02M Sell
67,403
-1,053
-2% -$92.7K 2.29% 10
2024
Q3 		$5.74M Buy
68,456
+1,210
+2% +$95.4K 2.21% 14
2024
Q2 		$5.18M Sell
67,246
-2,217
-3% -$162K 2.08% 18
2024
Q1 		$4.76M Sell
69,463
-1,220
-2% -$78.4K 1.93% 23
2023
Q4 		$4.09M Sell
70,683
-371
-0.5% -$19.8K 1.78% 29
2023
Q3 		$3.75M Buy
71,054
+936
+1% +$49.1K 1.81% 26
2023
Q2 		$3.79M Buy
70,118
+685
+1% +$35.8K 1.77% 28
2023
Q1 		$3.47M Buy
69,433
+2,302
+3% +$108K 1.73% 32
2022
Q4 		$3.11M Buy
67,131
+2,521
+4% +$109K 1.63% 32
2022
Q3 		$2.5M Buy
64,610
+923
+1% +$37K 1.44% 38
2022
Q2 		$2.37M Buy
63,687
+2,541
+4% +$103K 1.32% 39
2022
Q1 		$2.71M Buy
61,146
+5,950
+11% +$258K 1.3% 38
2021
Q4 		$2.35M Buy
55,196
+9,537
+21% +$401K 1.11% 42
2021
Q3 		$1.98M Buy
45,659
+1,696
+4% +$75K 4.78% 9
2021
Q2 		$1.88M Buy
43,963
+995
+2% +$41.9K 3.99% 10
2021
Q1 		$1.66M Buy
42,968
+3,128
+8% +$118K 1.41% 30
2020
Q4 		$1.43M Buy
39,840
+5,996
+18% +$216K 0.86% 50
2020
Q3 		$1.29M Buy
33,844
+3,971
+13% +$153K 0.87% 49
2020
Q2 		$1.05M Buy
29,873
+3,719
+14% +$134K 0.76% 49
2020
Q1 		$853K Buy
26,154
+10,377
+66% +$405K 0.74% 48
2019
Q4 		$712K Buy
15,777
+3,411
+28% +$143K 0.49% 52
2019
Q3 		$503K Buy
12,366
+6,520
+112% +$276K 0.38% 56
2019
Q2 		$251K Buy
+5,846
New +$225K 0.19% 75

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RBA Wealth Management's BSX Position: Q2 2026 in Review

RBA Wealth Management increased its Boston Scientific (BSX) stake by 12% in Q2 2026, buying an estimated $406K and bringing the position to 71,213 shares worth $3.04M. The position accounts for 1.12% of the portfolio, ranked #43.

RBA Wealth Management first reported a position in BSX in Q2 2019 and has held it in 29 quarters since. The position peaked at $6.8M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • RBA Wealth Management held 71,213 shares of Boston Scientific worth $3.04M as of Q2 2026.
  • RBA Wealth Management bought 7,476 Boston Scientific shares in Q2 2026, an estimated $406K.
  • Boston Scientific made up 1.12% of RBA Wealth Management's portfolio in Q2 2026, its #43 holding.
  • RBA Wealth Management first reported a position in Boston Scientific in Q2 2019 and has held it in 29 quarters since.
  • RBA Wealth Management's Boston Scientific position peaked at $6.8M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on RBA Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.